CNTA vs. MBX

Last updated Aug 1, 2026

CNTA (Centessa Pharmaceuticals Limited) and MBX (MBX Biosciences, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.24 correlation means their historical movements had little consistent relationship.

Performance

CNTA vs. MBX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Centessa Pharmaceuticals Limited (CNTA) and MBX Biosciences, Inc (MBX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNTA

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

MBX

• 1D: -0.80%
• 1M: 14.07%
• 6M: 78.91%
• YTD: 109.04%
• 1Y: 379.49%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 75.19%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
MBX MBX Biosciences, Inc	$35.29M	$45.81M	$39.35M

CNTA vs. MBX - Yearly Performance Comparison

	2026 (YTD)	2025	2024
CNTA Centessa Pharmaceuticals Limited	61.94%	49.31%	10.93%
MBX MBX Biosciences, Inc	109.04%	71.13%	-19.87%

Correlation

The correlation between CNTA and MBX is 0.23, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.23
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024	0.24

Fundamentals

EPS CNTA : -$1.81 MBX : -$2.22
Total Revenue (TTM) CNTA : $15.00M MBX : $0.00
Gross Profit (TTM) CNTA : $15.00M MBX : -$160.00K
EBITDA (TTM) CNTA : -$227.27M MBX : -$96.31M

Return for Risk

CNTA vs. MBX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CNTA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

MBX

MBX Risk / Return Rank: 97
MBX Sharpe Ratio Rank: 97
MBX Sortino Ratio Rank: 98
MBX Omega Ratio Rank: 96
MBX Calmar Ratio Rank: 99
MBX Martin Ratio Rank: 98

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CNTA vs. MBX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Centessa Pharmaceuticals Limited (CNTA) and MBX Biosciences, Inc (MBX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNTA	MBX	Difference
Sharpe ratio: Return per unit of total volatility	—	3.02	—
Sortino ratio: Return per unit of downside risk	—	4.31	—
Omega ratio: Gain probability vs. loss probability	—	1.50	—
Calmar ratio: Return relative to maximum drawdown	—	10.66	—
Martin ratio: Return relative to average drawdown	—	20.82	—

Drawdowns

Drawdown Indicators

	CNTA	MBX	Difference
Max Drawdown Largest peak-to-trough decline	—	-77.71%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-37.60%	—
Current Drawdown Current decline from peak	—	-0.80%	—
Average Drawdown Average peak-to-trough decline	—	-32.68%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	19.21%	—

Volatility

Volatility by Period

	CNTA	MBX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	22.35%	—
Volatility (6M) Calculated over the trailing 6-month period	—	54.44%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	133.51%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	116.49%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	116.49%	—

Dividends

CNTA vs. MBX - Dividend Comparison

Neither CNTA nor MBX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CNTA and MBX in my portfolio?

CNTA and MBX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.